| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5a95d4999542f2d9fa147bfed0e90cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
1992-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd6a280f980437926ba078e773ac3e67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f15cee5e08372dd0f697654b8b22b056 |
| publicationDate |
1993-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9310778-A1 |
| titleOfInvention |
Inhibition of angiogenesis with pyridinyloxazole-2-ones |
| abstract |
This invention is directed to pyridinyloxazole-2-ones which are useful in inhbiting angiogenesis in patients having cancer. The pyridinyloxazole-2-ones act to inhibit protein kinase C and thereby modulate angiogenesis. |
| priorityDate |
1991-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |